Fuller & Thaler Asset Management, Inc. Haemonetics Corp Transaction History

Fuller & Thaler Asset Management, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 06, 2020	SELL	$74.34 - $121.82 $3,642 - $5,969	-49 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$117.16 - $138.52 $6,326 - $7,480	-54 Reduced 52.43%	49 $6,000
Q1 2019 May 14, 2019	SELL	$83.25 - $102.12 $8,824 - $10,824	-106 Reduced 50.72%	103 $9,000
Q4 2018 Feb 14, 2019	SELL	$90.66 - $116.63 $42.1 Million - $54.1 Million	-464,104 Reduced 99.95%	209 $21,000
Q3 2018 Nov 13, 2018	SELL	$89.96 - $114.58 $24.4 Million - $31.1 Million	-271,231 Reduced 36.87%	464,313 $53.2 Million
Q2 2018 Aug 07, 2018	SELL	$71.53 - $95.75 $1.01 Million - $1.35 Million	-14,085 Reduced 1.88%	735,544 $66 Million
Q1 2018 May 14, 2018	SELL	$60.72 - $74.41 $88,104 - $107,968	-1,451 Reduced 0.19%	749,629 $54.8 Million
Q4 2017 Feb 14, 2018	BUY	$44.96 - $58.99 $9,936 - $13,036	221 Added 0.03%	751,080 $43.6 Million
Q4 2017 Feb 12, 2018	SELL	$44.96 - $58.99 $48.5 Million - $63.6 Million	-1,078,414 Reduced 58.95%	750,859 $43.6 Million
Q3 2017 Nov 08, 2017	SELL	$40.38 - $44.87 $15.8 Million - $17.5 Million	-390,724 Reduced 17.6%	1,829,273 $82.1 Million
Q2 2017 Aug 14, 2017	BUY	N/A	2,219,997	2,219,997 $87.7 Million

333

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.54B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Fuller & Thaler Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Fuller & Thaler Asset Management, Inc. with notifications on news.